🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the clinical anti-proliferative acti...
Status
Unknown
Location
Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Università degli Studi di Bologna
Start Date
2003-03
Trial ID
NCT00276926
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The purpose of this clinical research study is to compare the confirmed com...
Status
Completed
Location
Molecular Md
Start Date
2007-09
Trial ID
NCT00481247
RATIONALE: Drugs used in chronic-phase chronic myelogenous leukemia (CML) a...
Status
Unknown
Location
the First Affiliated Hospital of Harbin Medical University
Start Date
2018-05-01
Trial ID
NCT03515018
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxy...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2004-10
Trial ID
NCT00100997
Treatments Being Tested
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The suppression of the immune system creates a permissive environment for d...
Status
Unknown
Location
Multiple Locations
Start Date
2017-08-05
Trial ID
NCT03214718
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
Imatinib mesylate may stop the growth of tumor cells by blocking the enzyme...
Status
Terminated
Location
Cancer and Leukemia Group B
Start Date
2002-06
Trial ID
NCT00042952
Treatments Being Tested
The objective of this study is to determine the efficacy and safety of imat...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00154349
Treatments Being Tested